Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nicola Latronico and Francesco Castelli.
Nicola Latronico
Connection Strength
0.711
Francesco Castelli
  1. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.220
  2. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care. 2020 08; 58:29-33.
    View in: PubMed
    Score: 0.219
  3. Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2021 Jun; 3(6):e0430.
    View in: PubMed
    Score: 0.059
  4. Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience. Bioanalysis. 2020 Sep; 12(17):1223-1230.
    View in: PubMed
    Score: 0.056
  5. Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy. Kidney Int Rep. 2020 May; 5(5):580-585.
    View in: PubMed
    Score: 0.055
  6. SARS-CoV-2 invades the West. How to face a COVID-19 epidemic in Lombardy, Northern Italy? Infez Med. 2020 Ahead of print Jun 1; 28(2):133-134.
    View in: PubMed
    Score: 0.054
  7. Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report. Int J Infect Dis. 2018 Jul; 72:3-5.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.